United Therapeutics Corp at Morgan Stanley Global Healthcare Conference Transcript
Great. Well, thanks for joining us, everybody. I'm Terence Flynn, the U.S. Biopharma Analyst here at Morgan Stanley. Very pleased to have United Therapeutics with us.
Before we get started, I have to read a disclosure. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
Joining us today from the company, we have James Edgemond, who is the company's CFO; and Dewey Steadman, who is Head of Investor Relations. Thank you, both for being here. Really appreciate it.
Dewey, I'm going to turn it over to you for your disclosures, and then we'll get started.
Thanks, Terence. I appreciate it, and good afternoon, everyone. Just as a reminder, remarks today that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |